gross gambling revenue
AMRI (NASDAQ: AMRI) today reported financial and operating results for the second quarter ended June 30, 2008. Financial highlights for the quarter and other recent events include: -- Adjusted Diluted EPS of $0. 24, compared to $0. 14 in the second quarter of 2007.-- Double-digit year-over-year contract revenue growth in both Discovery Services and Development/Small Scale. The combined gross margin for this segment increased to 36% from 26% on a year-over-year basis.-- Year-over-year increase in adjusted operating income to $11. 0 million from $6. 6 million, a 68% increase.-- The submission of a Canadian Clinical Trial Application (CTA) by Bristol-Myers Squibb (BMS) triggering a $4. roulette new york how does sports gambling workj binions gambling hall and casino boards casino free game googlepray
